Ovation Topical CBD Products to Be Sold in the USA, UK and Europe
VANCOUVER, BC and LAS VEGAS, March 28, 2023 /PRNewswire/ – (CSE: OVAT) (OTCQB: OVATF) – Ovation Science Inc. (“Ovation” or the “Company”), a topical and transdermal cannabis product development company with a patented skin delivery technology Invisicare®, announces it has signed a Supply and Distribution Agreement with Golfer’s CBD Ltd., an international CBD brand focused on the health and wellness of golfers around the world. The Agreement covers the rights in the golf market for the United States, the United Kingdom and Europe.
According to a recent survey, there are 66.6 million golf players in the world. Since 2019, Golfer’s CBD Ltd. has been successfully targeting these players initially in the UK and then through the addition of a distribution partner in Central Europe and Scandinavia since 2021 (https://golferscbd.co.uk/). The company sells its portfolio of CBD golf health and wellness products, designed and branded specifically for the golf industry through its e-commerce channels utilizing a robust AI-based (Artificial intelligence) online marketing engine, social media and through retail distribution partners. Recently the company has expanded to the United States and has formed a partnership in order to bring its brand of products through-out Europe and to other countries around the world. The product line covers a range of CBD products from CBD gummies to oils and now Ovation’s transdermal creams, all designed to enhance golfers’ game preparation, playing skills and recovery.
“We are excited to have Golfer’s CBD Ltd. introduce two of Ovation’s transdermal formulations initially and make them available internationally. Since Ovation’s creams contain CBD (Cannabidiol) which is non-psychoactive, it provides these athletes with a wide-range of health and mental benefits before, during and after their game; whether they are amateur or pro,” said Terry Howlett, CEO of Ovation Science. He added, “The marketing program that Golfer’s CBD Ltd. has in place, will allow for Ovation to see immediate revenue on a monthly basis and even more significant sales revenue once other pending distribution agreements are finalized outside of the USA.”
